  See all
 |
Articles: Clinical Pharmacology |
Prior Articles
Tolterodine extended release is well tolerated in older subjects
International Journal of Clinical Practice, 08/05/09
Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
British Journal of Cancer, 08/05/09
Exclusive Author Commentary Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy
Cancer, 08/04/09 Evidence-based prescription of antibiotics in urology: a 5-year review of microbiology
BJU International, 08/04/09
Exclusive Author Commentary Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer
Clinical Cancer Research, 08/04/09 Effect of Tadalafil on Renal Resistivity and Pulsatility Index in Partial Ureteral Obstruction
Urologia Internationalis, 08/03/09 Intravesical Immunotherapy of Superficial Bladder Cancer with Chitosan/Interleukin-12
Cancer Research, 08/03/09 Sunitinib malate for metastatic castration-resistant prostate cancer following docetaxel-based chemotherapy
Annals of Oncology, 07/31/09
Exclusive Author Commentary A phase II study of docetaxel and oxaliplatin for second-line treatment of urothelial carcinoma
Chemotherapy, 07/31/09 Acceptance of and Discontinuation Rate from Paroxetine Treatment in Patients with Lifelong Premature Ejaculation
The Journal of Sexual Medicine, 07/31/09 Alfuzosin 10 mg Once Daily Increases the Chances of Successful Trial without Catheter after Acute Urinary Retention Secondary to Benign Prostate Hyperplasia
Urologia Internationalis, 07/30/09 Ejaculatory Disorders Caused by Alpha-1 Blockers for Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: Comparison of Naftopidil and Tamsulosin in a Randomized Multicenter Study
Urologia Internationalis, 07/30/09 Efficacy of carboplatin–taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials
Annals of Oncology, 07/30/09 Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
Annals of Oncology, 07/29/09 Diary and Patient-Reported Outcomes in Patients with Severe Overactive Bladder Switching from Tolterodine Extended Release 4 mg/day to Solifenacin Treatment: An Open-Label, Flexible-Dosing, Multicentre Study
Clinical Drug Investigation, 07/29/09 Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention
Supportive Care in Cancer, 07/29/09
Free full text
Thromboprophylaxis in Radical Retropubic Prostatectomy: Efficacy and Patient Compliance of a Dual Modality
Urologia Internationalis, 07/29/09 The effect of antimuscarinics on bladder filling sensations in healthy subjects - A placebo controlled double blind investigation using 4 and 8 mg tolterodine extended release
Neurourology and Urodynamics, 07/29/09 Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release
Neurourology and Urodynamics, 07/28/09 Efficacy and Safety of Oxybutynin Transdermal System in Spinal Cord Injury Patients With Neurogenic Detrusor Overactivity and Incontinence: An Open-label, Dose-titration Study
Urology, 07/28/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Urology, Journal of Urology, European Urology, The Prostate
more...
|
250 Available Pages
|
|
